Distribution of fibroblast growth factor-2 (FGF-2) within model excisional wounds following topical application

Journal of Pharmacy and Pharmacology

Volumn 61, Issue 2, 2009, Pages 193-200

  Braund, Rhiannon ^a   Hook, Sarah M ^a   Greenhill, Nicholas ^a   Medlicott, Natalie J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Fibroblast growth factor 2 (FGF 2); Growth factors; Hypromellose; Wound healing

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; HYDROXYPROPYLMETHYLCELLULOSE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FILM; NONHUMAN; PUNCH BIOPSY; RAT; STATISTICAL SIGNIFICANCE; SUBCUTANEOUS FAT; SURFACE PROPERTY; WOUND; WOUND HEALING;

EID: 59049084370     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.61.02.0008     Document Type: Article

References (43)

1. Bennett NT, Schultz GS. Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am J Surg 1993; 166: 74-81.
2. Falanga V. Chronic wounds: pathophysiologic and experimental considerations. J Invest Dermatol 1993; 100: 721-725.
3. Colville-Nash PR, Willoughby DA. Growth factors in angio- genesis: current interest and therapeutic potential. Mol Med Today 1997; 3: 14-23.
4. Harding KG et al. Science, medicine and the future: healing chronic wounds. BMJ 2002; 324: 160-163.
5. Martin A et al. Abnormal angiogenesis in diabetes mellitus. Med Res Rev 2003; 23: 117-145.
6. Stadelmann WK et al. Physiology and healing dynamics of chronic cutaneous wounds. Am J Surg 1998; 176: 26S-38S.
7. Robson MC et al. Wound healing: biologic features and approaches to maximize healing trajectories. Curr Prob Surg 2001; 38: 72-140.
8. Braund R et al. The role of topical growth factors in chronic wounds. Curr Drug Deliv 2007; 4: 195-204.
9. Cross SE, Roberts MS. Defining a model to predict the distribution of topically applied growth factors and other solutes in excisional full-thickness wounds. J Invest Derm 1999; 112: 36-41.
10. Robertson JG et al. Clearance of IGFs and insulin from wounds: effect of IGF-binding protein interactions. Am J Physiol 1999; 276: E663-E671.
11. Kawai K et al. Accelerated tissue regeneration through incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis. Biomaterials 2000; 21: 489-499.
12. Yager DR et al. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J Invest Dermatol 1996; 107: 743-748.
13. Trengove NJ et al. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen 2000; 8: 13-25.
14. Nimni ME. Polypeptide growth factors: targeted delivery systems. Biomaterials 1997; 18: 1201-1225.
15. Kiritsy CP et al. Role of growth factors in cutaneous wound healing: a review. Crit Rev Oral Biol Med 1993; 4: 729-760.
16. Mutsaers SE et al. Mechanisms of tissue repair: from wound healing to fibrosis. Int J Biochem Cell Biol 1997; 29: 5-17.
17. Cross MJ, Claesson-Welsh L. FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 2001; 22: 201-207.
18. Greenhalgh DG et al. PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 1990; 136: 1235-1246.
19. Tsuboi R, Rifkin DB. Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice. J Exp Med 1990; 172: 245-251.
20. Nissen NN et al. Basic fibroblast growth factor mediates angiogenic activity in early surgical wounds. Surgery 1996; 119: 457-465.
21. Botta M et al. Fibroblast growth factors and their inhibitors. Curr Pharma Des 2000; 6: 1897-1924.
22. Abraham J, Klagsbrun M. Modulation of wound repair by members of the fibroblast growth factor family. In: Clark RA, ed. The Molecular and Cellular Biology of Wound Repair. New York: Plenum Press, 1998: 195-248.
23. Buerk AA et al. Advances in wound healing. Curr Opin Orthop 2000; 11: 92-98.
24. Okumura M et al. Acceleration of wound healing in diabetic mice by basic fibroblast growth factor. Biol Pharm Bull 1996; 19: 530-535.
25. Bennett NT, Schultz GS. Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg 1993; 165: 728-737.
26. Pierce GF, Mustoe TA. Pharmacologic enhancement of wound healing. Ann Rev Med 1995; 46: 467-481.
27. O'Goshi K, Tagami H. Basic fibroblast growth factor treatment for various types of recalcitrant skin ulcers: reports of nine cases. J Dermatol Treat 2007; 18: 375-381.
28. Kawai K et al. Accelerated wound healing through the incorporation of basic fibroblast growth factor-impregnated gelatin microspheres into artificial dermis using a pressure- induced decubitus ulcer model in genetically diabetic mice. Br J Plast Surg 2005; 58: 1115-1123.
29. Andreopoulos FM, Persaud I. Delivery of basic fibroblast growth factor (bFGF) from photoresponsive hydrogel scaffolds. Biomaterials 2006; 27: 2468-2476.
30. Braund R et al. Hypromellose films for the delivery of growth factors for wound healing. J Pharm Pharmacol 2007; 59: 367-372.
31. Gardner-Thorpe J. et al. Angiogenesis in tissue-engineered small intestine. Tissue Eng 2003; 9: 1255-1261.
32. Vardaxis NJ et al. Confocal laser scanning microscopy of porcine skin: implications for human wound healing studies. J Anat 1997; 190: 601-611.
33. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stats 1979; 6: 65-70.
34. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing, 2008. www.R-project.org
35. Prats PA et al. Disposition and receptor-site binding of (125)I- EGF after topical administration to skin wounds. Biopharm Drug Dispos 2002; 23: 67-76.
36. Huang S et al. Wound dressings containing bFGF-impregnated microspheres. J Microencapsul 2006; 23: 277-290.
37. Fujita M et al. Therapeutic angiogenesis induced by controlled release of fibroblast growth factor-2 from injectable chitosan/ non-anticoagulant heparin hydrogel in a rat hindlimb ischemia model. Wound Repair Regen 2007; 15: 58-65.
38. Cooper DM et al. Determination of endogenous cytokines in chronic wounds. Ann Surg 1994; 219: 688-691; discussion 691-692.
39. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003; 83: 835-870.
40. Edelman ER et al. Controlled and modulated release of basic fibroblast growth factor. Biomaterials 1991; 12: 619-626.
41. Jeon O et al. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glyco-lide) nanospheres and fibrin gel. Biomaterials 2006; 27:1598-1607.
42. Presta M et al. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 2005; 16: 159-178.
43. Lee SJ. Cytokine delivery and tissue engineering. Yonsei Med J 2000; 41: 704-719.